+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Forecast 2024-2030- Product Image
Global Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Forecast 2024-2030- Product Image
Sale

Global Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337787
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Discovery Market size was estimated at USD 62.38 billion in 2023, USD 71.12 billion in 2024, and is expected to grow at a CAGR of 14.10% to reach USD 157.13 billion by 2030.

Drug discovery is a multifaceted and intricate process that encompasses the identification of novel compounds, the elucidation of their biological targets, and the determination of their therapeutic potential for the treatment of diseases. This process is fundamental to developing new medicines and involves a collaborative effort among scientists from various disciplines, including biology, chemistry, pharmacology, and medicine. Rising research and development (R&D) expenditure in the pharmaceutical and biopharmaceutical industry and favorable government support for developing drug discovery platforms are propelling the market growth.

In addition, the increasing need to manage large amounts of data generated during preclinical studies is fueling market growth. The necessity of extensive capital for drug discovery and development and stringent norms for animal usage in drug discovery are hampering market growth. Technological advancements and innovations in drug discovery and the growing use of AI cloud to create a streamlined and automated approach to drug discovery are expected to be poised for significant growth in drug discovery.

Regional Insights

Americas represents a robust drug discovery infrastructure with significant investments in R&D, a strong presence of pharmaceutical giants, and a conducive regulatory environment. Increasing investment in healthcare infrastructure and growing need for medical innovation to address local health concerns are accelerating the need for drug discovery solutions in the Americas. In Europe, the need for drug discovery is fueled by advanced healthcare systems, substantial government and private funding, and a strong focus on innovation and collaboration across countries.

The Middle East and Africa exhibit growing need, with increased healthcare spending and initiatives to foster local pharmaceutical industries. The Asia-Pacific region is rapidly emerging as a significant player in the drug discovery market due to its large population, increasing economic prosperity, improvements in healthcare infrastructure, rising healthcare awareness, and government initiatives to support the biotechnology and pharmaceutical sectors.

Market Trends by Segment

  • Drug Type: Growing need for small molecule drugs with branded and generic products
  • Technology: Growing utilization of bioanalytical instruments and high throughput screening for initial drug discovery phases
  • Therapeutic Area: Increasing need of drug discovery for the development of oncology drugs
  • End User: Growing drug discovery use across pharmaceutical and biotechnology companies for developing new and improved drugs

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration

Evommune, Inc. collaborated with Accutar Biotechnology, Inc., specializing in AI-driven drug discovery, to co-develop therapies for debilitating dermatological conditions. This strategic collaboration intends to leverage Accutar's AI platform to accelerate Evommune's drug discovery and development process, circumventing traditional bottlenecks and paving the way for innovative treatments.

IGC Pharma signs agreement to adopt AI solutions into drug discovery

IGC Pharma signed an agreement with the University of Los Andes in Colombia to develop and adopt generative artificial intelligence (AI) solutions to detect, develop, and trial new drugs. Under the agreement, the company leverages generative AI to streamline the efficiency of its clinical trials, improve early Alzheimer’s disease detection approaches, and enhance drug interaction assessments.

University of Tsukuba and Astellas Confirm a Strategic Partnership

Astellas Pharma Inc. partnered with the University of Tsukuba to integrate targeted protein degradation technology into their portfolio, a pivotal step that enhances their research capabilities. The implementation of this innovative approach aims to transcend the limitations of traditional drug development by strategically degrading disease-causing proteins.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alacrita Holdings Limited, Astex Pharmaceuticals by Otsuka Pharmaceutical Co., Ltd., Astrazeneca PLC, Atomwise, Inc., BenevolentAI, Bio-Rad Laboratories, Inc., BioSymetrics Inc., Charles River Laboratories International, Inc., Chembridge Corporation, Cloud Pharmaceuticals, Inc., Dalriada Drug Discovery, Deciphera Pharmaceuticals, Inc., Evotec SE, F. Hoffmann-La Roche Ltd., GENFIT SA, Incyte Corporation, International Business Machines Corporation, Intra-Cellular Therapies Inc., Merck KGaA, Microsoft Corporation, NVIDIA Corporation, PerkinElmer, Inc., Pharmacelera SL, Piramal Group, Recursion Pharmaceuticals, Inc., Schrödinger, Inc., Shimadzu Corporation, and Thermo Fisher Scientific Inc.

This research report offers invaluable insights into various crucial aspects of the Drug Discovery Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising R&D Expenditure in the Pharmaceutical & Biopharmaceutical industry
5.1.1.2. Increasing Need to Manage Large Data Generated During Preclinical Studies
5.1.1.3. Favorable Government Support For the Development of Drug Discovery Platforms
5.1.2. Restraints
5.1.2.1. Requirement of Extensive Capital for Drug Discovery and Development
5.1.3. Opportunities
5.1.3.1. Technological Advancements and Innovations in Drug Discovery
5.1.3.2. Use of AI Cloud to Create a Streamlined and Automated Approach in Drug Discovery
5.1.4. Challenges
5.1.4.1. Stringent Norms for the Animal Usage in Drug Discovery
5.2. Market Segmentation Analysis
5.2.1. Drug Type: Growing need for small molecule drugs with branded and generic products
5.2.2. Technology: Growing utilization of bioanalytical instruments and high throughput screening for initial drug discovery phases
5.2.3. Therapeutic Area: Increasing need of drug discovery for the development of oncology drugs
5.2.4. End User: Growing drug discovery use across pharmaceutical and biotechnology companies for developing new and improved drugs
5.3. Market Trend Analysis
5.3.1. Preference for advanced and innovative drug discovery technologies in the Americas
5.3.2. Proliferating number of clinical trials and availability of tax-incentives for drug development across the Asia-Pacific
5.3.3. Supportive government funding and initiatives for drug discovery and development in the EMEA region
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
6. Drug Discovery Market, by Drug Type
6.1. Introduction
6.2. Biologic Drugs
6.3. Small Molecule Drugs
7. Drug Discovery Market, by Technology
7.1. Introduction
7.2. Bioanalytical Instruments
7.3. Biochips
7.4. Bioinformatics
7.5. Combinatorial Chemistry
7.6. High Throughput Screening
7.7. Nanotechnology
7.8. Pharmacogenomics
8. Drug Discovery Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular Disease
8.3. Digestive System Diseases
8.4. Infectious & Immune system Diseases
8.5. Neurology
8.6. Oncology
9. Drug Discovery Market, by End User
9.1. Introduction
9.2. Academics & Research Institutes
9.3. Contract Research Organizations
9.4. Pharmaceutical Companies
10. Americas Drug Discovery Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Drug Discovery Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Drug Discovery Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration
13.3.2. IGC Pharma signs agreement to adopt AI solutions into drug discovery
13.3.3. University of Tsukuba and Astellas Confirm a Strategic Partnership
13.3.4. Mestastop Raises USD 500k To Further Its Cancer Drug Discovery
13.3.5. Sosei and PharmEnable collaborate on another neurological drug
13.3.6. Novo Nordisk and Evotec launch translational drug discovery accelerator
13.3.7. Genesis Raises USD 200 Million For AI Drug Discovery Research
13.3.8. Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development
13.3.9. BenchSci Raises USD 95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND
13.3.10. Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
13.3.11. Recursion Plans USD 87.5m Acquisitions To Shore Up AI Drug Discovery
13.3.12. Eurofins Discovery Acquires CALIXAR, Expanding Integrated Drug Discovery Capabilities and Expertise
13.3.13. PerkinElmer Unveils Multimode Plate Reader To Expedite Drug Discovery
13.3.14. LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA
13.3.15. Incyte Announces FDA Approval Of Pemazyre (Pemigatinib) As Targeted Treatment For Myeloid/Lymphoid Neoplasms (MLNs) With FGFR1 Rearrangement
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. DRUG DISCOVERY MARKET RESEARCH PROCESS
FIGURE 2. DRUG DISCOVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG DISCOVERY MARKET DYNAMICS
FIGURE 7. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG DISCOVERY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DRUG DISCOVERY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOCHIPS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOCHIPS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS & IMMUNE SYSTEM DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS & IMMUNE SYSTEM DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 75. CANADA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 76. CANADA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 77. CANADA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 78. CANADA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 79. CANADA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 80. CANADA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 81. CANADA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 82. CANADA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 83. MEXICO DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 84. MEXICO DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 85. MEXICO DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. MEXICO DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. MEXICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 88. MEXICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 89. MEXICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 90. MEXICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 119. CHINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 120. CHINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 121. CHINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 122. CHINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 123. CHINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 124. CHINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 125. CHINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 126. CHINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 127. INDIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 128. INDIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 129. INDIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 130. INDIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 131. INDIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 132. INDIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 133. INDIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 134. INDIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 141. INDONESIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 142. INDONESIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 143. JAPAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 144. JAPAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 145. JAPAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 146. JAPAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 147. JAPAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 148. JAPAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 149. JAPAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 150. JAPAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 157. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 158. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 165. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 166. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 173. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 174. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 181. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 182. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 189. TAIWAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 190. TAIWAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 191. THAILAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 192. THAILAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 193. THAILAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 194. THAILAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 195. THAILAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 196. THAILAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 197. THAILAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 198. THAILAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 205. VIETNAM DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 206. VIETNAM DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 217. DENMARK DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 218. DENMARK DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 219. DENMARK DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 220. DENMARK DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 221. DENMARK DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 222. DENMARK DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 223. DENMARK DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 224. DENMARK DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 225. EGYPT DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 226. EGYPT DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 227. EGYPT DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 228. EGYPT DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 229. EGYPT DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 230. EGYPT DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 231. EGYPT DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 232. EGYPT DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 233. FINLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 234. FINLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 235. FINLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 236. FINLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 237. FINLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 238. FINLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 239. FINLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 240. FINLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 241. FRANCE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 242. FRANCE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 243. FRANCE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 244. FRANCE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 245. FRANCE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 246. FRANCE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 247. FRANCE DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 248. FRANCE DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 249. GERMANY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 250. GERMANY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 251. GERMANY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 252. GERMANY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 253. GERMANY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 254. GERMANY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 255. GERMANY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 256. GERMANY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 263. ISRAEL DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 264. ISRAEL DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 265. ITALY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 266. ITALY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 267. ITALY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 268. ITALY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 269. ITALY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 270. ITALY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 271. ITALY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 272. ITALY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 279. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 280. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 287. NIGERIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 288. NIGERIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 289. NORWAY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 290. NORWAY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 291. NORWAY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 292. NORWAY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 293. NORWAY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 294. NORWAY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 295. NORWAY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 296. NORWAY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 297. POLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 298. POLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 299. POLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 300. POLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 301. POLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 302. POLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 303. POLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 304. POLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 305. QATAR DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 306. QATAR DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 307. QATAR DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 308. QATAR DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 309. QATAR DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 310. QATAR DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 311. QATAR DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 312. QATAR DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 315. RUSSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 316. RUSSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 317. RUSSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 318. RUSSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 319. RUSSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 320. RUSSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 324. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 326. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 328. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 330. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 332. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 334. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 336. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 337. SPAIN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 338. SPAIN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 339. SPAIN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 340. SPAIN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 341. SPAIN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 342. SPAIN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 343. SPAIN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 344. SPAIN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 345. SWEDEN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 346. SWEDEN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 347. SWEDEN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 348. SWEDEN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 349. SWEDEN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 350. SWEDEN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 351. SWEDEN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 352. SWEDEN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 353. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 354. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 355. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 356. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 357. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 358. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 359. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 360. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 361. TURKEY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 362. TURKEY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 363. TURKEY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 364. TURKEY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 365. TURKEY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 366. TURKEY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 367. TURKEY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 368. TURKEY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 369. UNIT

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alacrita Holdings Limited
  • Astex Pharmaceuticals by Otsuka Pharmaceutical Co., Ltd.
  • Astrazeneca PLC
  • Atomwise, Inc.
  • BenevolentAI
  • Bio-Rad Laboratories, Inc.
  • BioSymetrics Inc.
  • Charles River Laboratories International, Inc.
  • Chembridge Corporation
  • Cloud Pharmaceuticals, Inc.
  • Dalriada Drug Discovery
  • Deciphera Pharmaceuticals, Inc.
  • Evotec SE
  • F. Hoffmann-La Roche Ltd.
  • GENFIT SA
  • Incyte Corporation
  • International Business Machines Corporation
  • Intra-Cellular Therapies Inc.
  • Merck KGaA
  • Microsoft Corporation
  • NVIDIA Corporation
  • PerkinElmer, Inc.
  • Pharmacelera SL
  • Piramal Group
  • Recursion Pharmaceuticals, Inc.
  • Schrödinger, Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 71.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 157.13 Billion
Compound Annual Growth Rate14.1%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Global Drug Discovery Technologies Market by Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Drug Type (Biologic Drugs, Small-molecule Drugs), End User - Forecast 2024-2030 - Product Image

Global Drug Discovery Technologies Market by Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Drug Type (Biologic Drugs, Small-molecule Drugs), End User - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Global Drug Discovery Services Market by Process (Candidate Validation, Hit-to-Lead Identification, Lead Optimization), Drug Type (Biologics, Small Molecules), Service type, Therapeutic Area, End-user - Forecast 2024-2030 - Product Image

Global Drug Discovery Services Market by Process (Candidate Validation, Hit-to-Lead Identification, Lead Optimization), Drug Type (Biologics, Small Molecules), Service type, Therapeutic Area, End-user - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Small Molecule Drug Discovery - Global Strategic Business Report - Product Image

Small Molecule Drug Discovery - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Small Molecule Drug Discovery Global Market Report 2024 - Product Image

Small Molecule Drug Discovery Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Artificial Intelligence / AI in Drug Discovery Market by Offering, Process (Target selection, Validation, Lead Generation, Optimization), Drug Design (Small Molecule, Vaccine, Antibody, PK/PD), Dry Lab, Wet Lab (Single Cell analysis) & Region - Global Forecast to 2028 - Product Image

Artificial Intelligence / AI in Drug Discovery Market by Offering, Process (Target selection, Validation, Lead Generation, Optimization), Drug Design (Small Molecule, Vaccine, Antibody, PK/PD), Dry Lab, Wet Lab (Single Cell analysis) & Region - Global Forecast to 2028

  • Report
  • 369 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.